These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18952366)

  • 1. Editorial comment on: Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Seitz M; Gratzke C
    Eur Urol; 2009 Mar; 55(3):591. PubMed ID: 18952366
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
    Vilanova JC; Barceló J
    Abdom Imaging; 2007; 32(2):253-61. PubMed ID: 17476554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D MR spectroscopic imaging in the evaluation of prostate cancer.
    Rajesh A; Coakley FV; Kurhanewicz J
    Clin Radiol; 2007 Oct; 62(10):921-9. PubMed ID: 17765456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
    Sciarra A
    Eur Urol; 2008 Sep; 54(3):526-7. PubMed ID: 18571308
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
    Sciarra A; Salciccia S; Panebianco V
    Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional magnetic resonance imaging in prostate cancer.
    Seitz M; Shukla-Dave A; Bjartell A; Touijer K; Sciarra A; Bastian PJ; Stief C; Hricak H; Graser A
    Eur Urol; 2009 Apr; 55(4):801-14. PubMed ID: 19185981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of imaging in the oncological prostate.
    Chabanova E; Lögager VB
    Acta Radiol; 2008 Feb; 49(1):4. PubMed ID: 18210305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Magnetic resonance spectroscopy. A new technic for the study and the diagnosis of prostatic disease].
    García-Segura JM; Sánchez Chapado M
    Arch Esp Urol; 1995 Jun; 48(5):423-46. PubMed ID: 7543739
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
    Lawrentschuk N; Fleshner N
    BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW; Cheng LL
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leiomyosarcoma of the rectum versus prostatic malignancy. Differentiation by magnetic resonance imaging.
    Hamlin DJ; Pettersson H; Wajsman Z; Bland K; Hackett RL
    Rofo; 1985 Oct; 143(4):482-4. PubMed ID: 2997885
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging modalities for prostate cancer.
    Fütterer JJ; Barentsz J; Heijmijnk ST
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):923-37. PubMed ID: 19589032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance imaging and prostate cancer].
    Cornud F; Villers A; Mongiat-Artus P; Rebillard X; Soulie M;
    Prog Urol; 2008 Nov; 18(10):621-33. PubMed ID: 18971104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
    Fuchsjäger M; Akin O; Shukla-Dave A; Pucar D; Hricak H
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):193-202. PubMed ID: 19398944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance in surgical oncology: II - literature review.
    Gluch L
    ANZ J Surg; 2005 Jun; 75(6):464-70. PubMed ID: 15943738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
    Coleman JA
    Eur Urol; 2008 Sep; 54(3):525-6. PubMed ID: 18571310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer].
    Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH
    Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.